Chronic myelogenous leukemia

Susan O'Brien; Ellin Berman; Hossein Borghaei; Daniel J. DeAngelo; Marcel P. Devetten; Steven Devine; Harry P. Erba; Jason Gotlib; Madan Jagasia; Joseph O. Moore; Tariq Mughal; Javier Pinilla-Ibarz; Jerald P. Radich; Neil P. Shah; Paul J. Shami; B. Douglas Smith; David S. Snyder; Martin S. Tallman; Moshe Talpaz; Meir Wetzler

doi:10.6004/jnccn.2009.0065

Chronic myelogenous leukemia

Susan O'Brien, Ellin Berman, Hossein Borghaei, Daniel J. DeAngelo, Marcel P. Devetten, Steven Devine, Harry P. Erba, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Tariq Mughal, Javier Pinilla-Ibarz, Jerald P. Radich, Neil P. Shah, Paul J. Shami, B. Douglas Smith, David S. Snyder, Martin S. Tallman, Moshe Talpaz, Meir Wetzler

Research output: Contribution to journal › Review article › peer-review

74 Scopus citations

Abstract

CML is a hematopoietic stem cell disease characterized by the presence of Ph chromosome resulting from the translocation between chromosomes 9 and 22 [t(9;22)].

Original language	English (US)
Pages (from-to)	984-1023
Number of pages	40
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	7
Issue number	9
DOIs	https://doi.org/10.6004/jnccn.2009.0065
State	Published - Oct 2009

Keywords

Allogenic HSCT
Chronic myelogenous leukemia
Cytogenetic response
Dasatinib
Hematologic response
Imatinib
Karyotyping
NCCN Clinical Practice Guidelines
Nilotinib
Transplantation

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2009.0065

Cite this

O'Brien, S., Berman, E., Borghaei, H., DeAngelo, D. J., Devetten, M. P., Devine, S., Erba, H. P., Gotlib, J., Jagasia, M., Moore, J. O., Mughal, T., Pinilla-Ibarz, J., Radich, J. P., Shah, N. P., Shami, P. J., Smith, B. D., Snyder, D. S., Tallman, M. S., Talpaz, M., & Wetzler, M. (2009). Chronic myelogenous leukemia. JNCCN Journal of the National Comprehensive Cancer Network, 7(9), 984-1023. https://doi.org/10.6004/jnccn.2009.0065

O'Brien, S, Berman, E, Borghaei, H, DeAngelo, DJ, Devetten, MP, Devine, S, Erba, HP, Gotlib, J, Jagasia, M, Moore, JO, Mughal, T, Pinilla-Ibarz, J, Radich, JP, Shah, NP, Shami, PJ, Smith, BD, Snyder, DS, Tallman, MS, Talpaz, M & Wetzler, M 2009, 'Chronic myelogenous leukemia', JNCCN Journal of the National Comprehensive Cancer Network, vol. 7, no. 9, pp. 984-1023. https://doi.org/10.6004/jnccn.2009.0065

@article{e353897d5df64f18b40947cbb7066fc7,

title = "Chronic myelogenous leukemia",

abstract = "CML is a hematopoietic stem cell disease characterized by the presence of Ph chromosome resulting from the translocation between chromosomes 9 and 22 [t(9;22)].",

keywords = "Allogenic HSCT, Chronic myelogenous leukemia, Cytogenetic response, Dasatinib, Hematologic response, Imatinib, Karyotyping, NCCN Clinical Practice Guidelines, Nilotinib, Transplantation",

author = "Susan O'Brien and Ellin Berman and Hossein Borghaei and DeAngelo, {Daniel J.} and Devetten, {Marcel P.} and Steven Devine and Erba, {Harry P.} and Jason Gotlib and Madan Jagasia and Moore, {Joseph O.} and Tariq Mughal and Javier Pinilla-Ibarz and Radich, {Jerald P.} and Shah, {Neil P.} and Shami, {Paul J.} and Smith, {B. Douglas} and Snyder, {David S.} and Tallman, {Martin S.} and Moshe Talpaz and Meir Wetzler",

year = "2009",

month = oct,

doi = "10.6004/jnccn.2009.0065",

language = "English (US)",

volume = "7",

pages = "984--1023",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "9",

}

TY - JOUR

T1 - Chronic myelogenous leukemia

AU - O'Brien, Susan

AU - Berman, Ellin

AU - Borghaei, Hossein

AU - DeAngelo, Daniel J.

AU - Devetten, Marcel P.

AU - Devine, Steven

AU - Erba, Harry P.

AU - Gotlib, Jason

AU - Jagasia, Madan

AU - Moore, Joseph O.

AU - Mughal, Tariq

AU - Pinilla-Ibarz, Javier

AU - Radich, Jerald P.

AU - Shah, Neil P.

AU - Shami, Paul J.

AU - Smith, B. Douglas

AU - Snyder, David S.

AU - Tallman, Martin S.

AU - Talpaz, Moshe

AU - Wetzler, Meir

PY - 2009/10

Y1 - 2009/10

N2 - CML is a hematopoietic stem cell disease characterized by the presence of Ph chromosome resulting from the translocation between chromosomes 9 and 22 [t(9;22)].

AB - CML is a hematopoietic stem cell disease characterized by the presence of Ph chromosome resulting from the translocation between chromosomes 9 and 22 [t(9;22)].

KW - Allogenic HSCT

KW - Chronic myelogenous leukemia

KW - Cytogenetic response

KW - Dasatinib

KW - Hematologic response

KW - Imatinib

KW - Karyotyping

KW - NCCN Clinical Practice Guidelines

KW - Nilotinib

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=72149087674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72149087674&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2009.0065

DO - 10.6004/jnccn.2009.0065

M3 - Review article

C2 - 19878641

AN - SCOPUS:72149087674

SN - 1540-1405

VL - 7

SP - 984

EP - 1023

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 9

ER -

Chronic myelogenous leukemia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this